RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - STUDIO COMPARATIVO SULLA RISPOSTA IMMUNITARIA VS STAPH.AUREUS DURANTE MASTITE SUBCLINICA NEL BOVINO E DOPO SOMMINISTRAZIONE DI UN VACCINO PROTEICO IN UN MODELLO MURINO DI MASTITE
• 2 - Dallo studio dell’espressione genica globale allo studio della virulenza di Mycobacterium tuberculosis
• 3 - INFEZIONE DEL CANE DA CORONAVIRUS PANTROPICO: ASPETTI EPIDEMIOLOGICI, PATOGENETICI E MOLECOLARI
• 4 - Ruolo zoonosico del virus dell'Epatite E (HEV) e virus HEV correlati nel contesto italiano
• 5 - Apoptosi e infezioni virali: aspetti molecolari
• 6 - Un approccio biomolecolare per la patologia HHV8-associata e la sua possibile trasformazione neoplastica:
• 7 - Struttura e funzioni nella patogenesi di proteine non catalitiche prodotte da Funghi e Oomiceti fitopatogeni.
• 8 - Caratterizzazione strutturale e funzionale di peptidi sintetici per lo sviluppo di strategie antivirali
• 9 - Infezioni virali persistenti, latenti e croniche da virus a DNA e ad RNA: studio dei meccanismi di regolazione genica e della risposta immune.
• 10 - Approcci vaccinali innovativi per il controllo delle infezioni erpetiche e papillomatose sessualmente trasmesse

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze agrarie e veterinarie
  • MALATTIE INFETTIVE DEGLI ANIMALI DOMESTICI

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators, containing micro-organisms, viruses, microbial fungi, enzymes, fermentates or substances produced by or extracted from micro-organisms or animal material A01N63/00; food compositions A21, A23; medicinal preparations A61K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A61L; fertilisers C05); PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS (preservation of living parts of humans or animals A01N1/02); MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (micro-biological testing media C12Q)
  • ORGANIC CHEMISTRY (such compounds as the oxides, sulfides, or oxysulfides of carbon, cyanogen, phosgene, hydrocyanic acid or salts thereof C01; products obtained from layered base-exchange silicates by ion-exchange with organic compounds such as ammonium, phosphonium or sulfonium compounds or by intercalation of organic compounds C01B33/44; macromolecular compounds C08; dyes C09; fermentation products C12; fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture C12P; production of organic compounds by electrolysis or electrophoresis C25B3/00, C25B7/00)
    • PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
• HUMAN NECESSITIES
  • MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES (bringing into special physical form A61J [N: mechanical aspects]; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; compounds per se C01, C07, C08, C12N; soap compositions C11D; micro-organisms per se C12N) [C0203]
    • VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS

Classificazione geografica

• Regione: Emilia Romagna

Bibliografia

1. Becher P., Orlich M., Shannon A.D., Horner G., Konig M., Thiel H-J. (1997). Phylogenetic analysis of Pestiviruses from domestic and wild ruminants. Journal of general Virology. 78, 1357-1366.
2. Beer, M., Wolf, G., Pichler, J., Wolfmeyer, A., Kaaden, O.R., 1997. Cytotoxic T-lymphocyte responses in cattle infected with bovine viral diarrhoea virus. Veterinary Microbiology 58, 9-22.
3. Bhudevi B. and Weinstock D., (2001). Fluorogenic RT-PCR assay (TaqMan) for detection and classification of bovine viral diarrhea virus. Vet.Microbiol., 83, 1-10.
4. Bolin SR. e Grooms DL. (2004). Origination and consequences of bovine viral diarrhea virus diversity. Veterinary Clinics of North America. Food Animal Practice, 20, 51-68.
5. Brock K.V. (1995). Diagnosis of bovine viral diarrhea virus infections. Vet. Clin. North. Am., 11, 549-561.
6. Chase C.C.L., Elmowalid G., Yousif A.A. 2004. The immune response to bovine viral diarrhea virus: a constantly changing picture. Veterinary Clinics of North America 20, 95-114.
7. Collen, T. & Morrison, W.I., 2000. CD4+ T-cell responses to bovine viral diarrhoea virus in cattle. Virus Research 67, 67-80.
8. Deregt, D., Van Rijn, P.A., Wiens, T.Y., Van den Hurk, J., 1998. Monoclonal antibodies to the E2 protein of a new genotype (type2) of a bovine viral diarrhea virus define three antigenic domains involved in neutralization. Virus Research 57, 171-181.
9. DesCoteaux L, Cecyre D, Elsener J, Beauchamp G. Comparison of humoral immune responses in dairy heifers vaccinated with 3 different commercial vaccines against bovine viral diarrhea virus and bovine herpesvirus-1. Can Vet J. 2003 Oct;44(10):816-21.
10. Domingo E. (1998). Quasispecies and the implications for virus persistence and escape. Clinical and Diagnostic Virology. 10, 97-101
11. Donofrio G., Bottarelli E., Cavirani S., Flammini C.F. (2006). Expression of the Bovine Viral Diarrhea Virus glycoprotein E2 as a soluble secreted form in mammalian cell line. Clinical And Diagnostic Laboratory Immunology. vol. 13 ISSN: 1071-412X. La rivista è attualmente denominata "Clinical and Vaccine Immunology". Issue n.6, in press.
12. Endsley J.J., Quade M.J., Terhaar B., Roth J.A., 2002. Bovine viral diarrhea virus type 1- and 2- specific T Lymphocyte-subset responses following modified-live virus vaccination. Veterinary Therapeutics, 3, 364-372.
13. Entrican G., Dand A. & Nettleton P.F. (1995). A double monoclonal antibody ELISA for detecting pestivirus antigen in the blood of viraemic cattle and sheep. Vet. Microbiol., 43, 65-74.
14. Fairbanks KK, Rinehart CL, Ohnesorge WC, Loughin MM, Chase CC. Evaluation of fetal protection against experimental infection with type 1 and type 2 bovine viral diarrhea virus after vaccination of the dam with a bivalent modified-live virus vaccine. J Am Vet Med Assoc. 2004 Dec 15;225(12):1898-904.
15. Falcone E, Cordioli P, Tarantino M, Muscillo M, Sala G, La Rosa G, Archetti IL, Marianelli C, Lombardi G, Tollis M. Experimental infection of calves with bovine viral diarrhoea virus type-2 (BVDV-2) isolated from a contaminated vaccine. Vet Res Commun. 2003 Oct;27(7):577-89.
16. Fulton RW, Ridpath JF, Confer AW, Saliki JT, Burge LJ, Payton ME. Bovine viral diarrhoea virus antigenic diversity: impact on disease and vaccination programmes. Biologicals. 2003 Jun;31(2):89-
17. Giangaspero M, Harasawa R, Zecconi A, Luzzago C.: 2001. Genotypic characteristics of bovine viral diarrhea virus 2 strains isolated in northern Italy. J Vet Med Sci ;63(9):1045-9
18. Gilbert SA, Burton KM, Prins SE, Deregt D. (1999). Typing of bovine viral diarrhea viruses directly from blood of persistently infected cattle by multiplex PCR. J Clin Microbiol.; 37:2020-2023
19. Grooms D.L., Keilen E.D. (2002). Screening of neonatal calves for persistent infection with Bovine viral diarrhea virus by immunohistochemistry on skin biopsy samples. Clin. Diagn. Lab. Immunol., 9, 898-900.
20. Hamers C, Couvreur B, Dehan P, Letellier C, Fischer L, Brun AJ, Lewalle P, Michaux C, Pastoret Nobiron I, Thompson I, Brownlie J, Collins ME. DNA vaccination against bovine viral diarrhoea virus induces humoral and cellular responses in cattle with evidence for protection against viral challenge. Vaccine. 2003 May 16;21(17-18):2082-92.
21. Hilbe M., Zlinszky K., Ehrensperger F. (2000). Demonstration of Bovine Viral Diarrhea (BVD)-virus in hair root sheaths. Eur.J. Vet. Pathol., 6, 31-32.
22. Konig M., Cedillo Rosales S., Becher P., Thiel H.J., (2003). Heterogeneity of ruminant pestiviruses: academic interest or important basis for the development of vaccines and diagnostics? Berl. Munch. Tierarztl. Wochenschr. 116, 216-21.
23. Lopez, O.J., Osorio F.A., Kelling, C.L., Donis, R.O., 1993. Presence of bovine viral diarrhoea virus strains in lymphoid cell populations of persistently infected cattle. Journal of General Virology 74, 925-929.
24. Makoschey B, Janssen MG, Vrijenhoek MP, Korsten JH, Marel P. An inactivated bovine virus diarrhoea virus (BVDV) type 1 vaccine affords clinical protection against BVDV type 2. Vaccine. 2001 Apr 30;19(23-24):3261-8.
25. Meyers G., Thiel H.J. (1996). Molecular characterization of Pestivirus. Advan. Virus Res. 47, 53-118.
26. Moennig V, Eicken K, Flebbe U, Frey HR, Grummer B, Haas L, Greiser-Wilke I, Liess B. Implementation of two-step vaccination in the control of bovine viral diarrhoea (BVD). Prev Vet Med. 2005 Nov 15;72(1-2):109-14.
27. Moennig V, Houe H, Lindberg A. BVD control in Europe: current status and perspectives. Anim Health Res Rev. 2005 Jun;6(1):63-74.
28. Pande A, Carr BV, Wong SY, Dalton K, Jones IM, McCauley JW, Charleston B. The glycosylation pattern of baculovirus expressed envelope protein E2 affects its ability to prevent infection with bovine viral diarrhoea virus. Virus Res. 2005 Dec;114(1-2):54-62
29. Pratelli A, Martella V, Cirone F, Buonavoglia D, Elia G, Tempesta M, Buonavoglia C. (2001). Genomic characterization of pestiviruses isolated from lambs and kids in southern Italy. J. Virol. Methods., 94, 81-85.
30. Rhodes, S.G., Cocksedge, J.M., Collins, R.A., Morrison, W.I., 1999. Differential cytokine responses of CD4+ and CD8+ T cellsin response to bovine viral diarrhoea virus in cattle. Journal of General Virology 80, 1673-1679.
31. Rossmanith W, Vilcek S, Wenzl H, Rossmanith E, Loitsch A, Durkovic B, Strojny L, Paton DJ.: 2001. Improved antigen and nucleic acid detection in a bovine virus diarrhoea eradication program. Vet Microbiol 8;81(3):207-18.
32. Sopp, P., Hooper, L.B., Clarke, M.C., Howard. C.J., Brownlie, J., 1994. Detection of bovine viral diarrhoea virus p80 protein in subpopulations of bovine leukocytes. Journal of General Virology 75, 1189-1194.
33. Vilcek S., Durkovic B., Kolesàrovà M., Greiser-Wilkec I., Paton D.J. (2004). Genetic diversity of international bovine viral diarrhoea virus (BVDV) isolates: identificationof a new BVDV-1 genetic group. Veterinary Reserch 35, 609-615.
34. Wang L, Whitbeck JC, Lawrence WC, Volgin DV, Bello LJ. Expression of the genomic form of the bovine viral diarrhea virus E2 ORF in a bovine herpesvirus-1 vector. Virus Genes. 2003 Aug;27(1):83-91.

Parole Chiave

BVDV, EPIDEMIOLOGIA, DIAGNOSI, VACCINAZIONE